-transparent.png){kind=logo}
Synthetic atrial natriuretic factor (Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly -Leu- Gly-Cys-Asn-Ser-Phe-Arg-Tyr-COOH [disulfide bond between cysteines]) was infused intravenously into conscious normotensive and deoxycorticosterone, one-kidney, one-clip, and two-kidney, one-clip hypertensive rats. Mean arterial pressure, urine volume, and electrolyte excretion rates were measured during a 20-minute infusion of a single dose (ranging from 0-1520 pmol/min) into each animal; 95 to 380 pmol/minute of synthetic atrial natriuretic factor maximally reduced mean arterial pressure by -20 +/- 4, -29 +/- 2, and -39 +/- 7 mm Hg in normotensive, one-kidney, one-clip, and two-kidney, one-clip hypertensive rats, respectively. In deoxycorticosterone rats, a dose of 760 pmol/minute was required to produce the largest depressor response (-58 +/- 12 mm Hg). Sodium excretion increased to 8.8 +/- 2.5 muEq/minute at 760 pmol/minute in normotensive rats, to 6.5 +/- 1.1 muEq/minute at 50 pmol/minute in deoxycorticosterone rats, and to 5.8 +/- 1.5 muEq/minute at 95 pmol/minute in one-kidney, one-clip animals. The natriuretic effect was consistently greater at all doses of synthetic atrial natriuretic factor in the two-kidney, one-clip hypertensive model, in which the maximum response was 15.3 +/- 4.7 muEq/minute at 190 pmol/minute. The changes in urine volume and excretion rates of potassium and chloride tended to parallel the increases in sodium excretion in each model. Interestingly, the maximally effective hypotensive dose of synthetic atrial natriuretic factor was different from the maximally effective natriuretic dose in all four groups.(ABSTRACT TRUNCATED AT 250 WORDS)
A A Seymour, and
E A Marsh, and
E K Mazack, and
I I Stabilito, and
E H Blaine
January 1988,
Peptides,
A A Seymour, and
E A Marsh, and
E K Mazack, and
I I Stabilito, and
E H Blaine
March 1994,
Diabetes care,
A A Seymour, and
E A Marsh, and
E K Mazack, and
I I Stabilito, and
E H Blaine
December 1988,
European journal of pharmacology,
A A Seymour, and
E A Marsh, and
E K Mazack, and
I I Stabilito, and
E H Blaine
December 1989,
Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
A A Seymour, and
E A Marsh, and
E K Mazack, and
I I Stabilito, and
E H Blaine
September 1984,
European journal of pharmacology,
A A Seymour, and
E A Marsh, and
E K Mazack, and
I I Stabilito, and
E H Blaine
December 1985,
Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
A A Seymour, and
E A Marsh, and
E K Mazack, and
I I Stabilito, and
E H Blaine
April 1996,
Journal of hypertension,
A A Seymour, and
E A Marsh, and
E K Mazack, and
I I Stabilito, and
E H Blaine
October 1987,
Japanese circulation journal,
A A Seymour, and
E A Marsh, and
E K Mazack, and
I I Stabilito, and
E H Blaine
January 1985,
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
A A Seymour, and
E A Marsh, and
E K Mazack, and
I I Stabilito, and
E H Blaine
February 1988,
Journal of developmental physiology,
